Planned progressive antimicrobial therapy in neutropenic patients
- 1 September 1998
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 102 (4), 879-888
- https://doi.org/10.1046/j.1365-2141.1998.00848.x
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trialEuropean Journal of Cancer, 1996
- An approach to the design and implementation of clinical trials of empirical antibiotic therapy in febrile and neutropenic cancer patientsEuropean Journal of Cancer, 1995
- CeftazidimeDrugs, 1995
- Factors associated with bacteraemia in febrile, granulocytopenic cancer patientsEuropean Journal of Cancer, 1994
- A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow TransplantationNew England Journal of Medicine, 1992
- Fungal infections in cancer patients: An international autopsy surveyEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- Antifungal Prophylaxis with Itraconazole in Prolonged Neutropenia: Correlation with Plasma LevelsMycoses, 1989
- Vancomycin, Ticarcillin, and Amikacin Compared with Ticarcillin-Clavulanate and Amikacin in the Empirical Treatment of Febrile, Neutropenic Children with CancerNew England Journal of Medicine, 1988
- A Randomized Trial Comparing Ceftazidime Alone with Combination Antibiotic Therapy in Cancer Patients with Fever and NeutropeniaNew England Journal of Medicine, 1986
- Infections with Herpes Simplex VirusesNew England Journal of Medicine, 1986